Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy
Home
Publications
Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy
Incidence of and Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral Combination Therapy
Authors:
FW
Ferdinand W. N. M. Wit
Ferdinand W. N. M. Wit
GW
Gerrit Jan Weverling
Gerrit Jan Weverling
JW
Jan Weel
Jan Weel
SJ
Suzanne Jurriaans
Suzanne Jurriaans
JL
Joep M. A. Lange
Joep M. A. Lange
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Download PDF
Download
Open Access
Publisher website
Google Scholar
1 July 2002
journal article
Published by
Oxford University Press (OUP)
in
The Journal of Infectious Diseases
Vol. 186
(1)
,
23-31
DOI:
10.1086/341084
PMID:
12089658
Abstract
This retrospective cohort study investigated whether particular antiretroviral agents are associated with a higher risk for developing grade 4 liver
Keywords
ANTI-RETROVIRAL AGENTS
COMBINED MODALITY THERAPY
HEPATITIS B VIRUS
HEPATOTOXICITY
NEVIRAPINE
RITONAVIR
INFECTION
HEPATITIS B
CHRONIC
HIV
LIVER ENZYME
Related articles
Cited
Cited by 251 articles
Scroll to top